Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyang Sun

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2024
Selective ligand recognition and activation of somatostatin receptors SSTR1 and SSTR3Yujue Wang, Youwei Xu, Yue Wang, et al.
Cell Discovery|March 14, 2023
Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinomaLulu Sun, Xindan Kang, Chong Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2025
Research trends in the use of nanobodies for cancer therapyJun Hou, Kejiang Du, Jinling Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2019
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic AberrationsRong Zhou, Chaoji Shi, Wenjie Tao, et al.
International Journal of Oral Science|February 10, 2023
A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft modelsQi Wu, Lan Chen, Xiaojuan Huang, et al.
Theranostics|September 29, 2023
A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumorShuyang Sun, Ziqiang Ding, Li Gao, et al.
BMC Medicine|May 28, 2024
The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplificationChaoji Shi, Houyu Ju, Rong Zhou, et al.
JCI Insight|December 12, 2022
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancerJinmei Jin, Yaping Wu, Zeng Zhao, et al.
Nature Microbiology|October 2, 2019
Vibrio cholerae residing in food vacuoles expelled by protozoa are more infectious in vivoGustavo Espinoza-Vergara, Parisa Noorian, Cecilia A Silva-Valenzuela, et al.
Cell Proliferation|October 21, 2018
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinomaWenjuan Zhang, Yupei Liang, Lihui Li, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|October 3, 2024
Selective ligand recognition and activation of somatostatin receptors SSTR1 and SSTR3Yujue Wang, Youwei Xu, Yue Wang, et al.
Cell Discovery|March 14, 2023
Single-cell and spatial dissection of precancerous lesions underlying the initiation process of oral squamous cell carcinomaLulu Sun, Xindan Kang, Chong Wang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2025
Research trends in the use of nanobodies for cancer therapyJun Hou, Kejiang Du, Jinling Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2019
Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic AberrationsRong Zhou, Chaoji Shi, Wenjie Tao, et al.
International Journal of Oral Science|February 10, 2023
A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft modelsQi Wu, Lan Chen, Xiaojuan Huang, et al.
Theranostics|September 29, 2023
A dendritic/tumor fusion cell vaccine enhances efficacy of nanobody-based CAR-T cells against solid tumorShuyang Sun, Ziqiang Ding, Li Gao, et al.
BMC Medicine|May 28, 2024
The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplificationChaoji Shi, Houyu Ju, Rong Zhou, et al.
JCI Insight|December 12, 2022
Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancerJinmei Jin, Yaping Wu, Zeng Zhao, et al.
Nature Microbiology|October 2, 2019
Vibrio cholerae residing in food vacuoles expelled by protozoa are more infectious in vivoGustavo Espinoza-Vergara, Parisa Noorian, Cecilia A Silva-Valenzuela, et al.
Cell Proliferation|October 21, 2018
The Nedd8-activating enzyme inhibitor MLN4924 (TAK-924/Pevonedistat) induces apoptosis via c-Myc-Noxa axis in head and neck squamous cell carcinomaWenjuan Zhang, Yupei Liang, Lihui Li, et al.
Pageof 9